Effect of cyclophosphamide and levan treatment on bone marrow and peripheral blood cells in B16-F10 melanoma-bearing mice
- 1 January 1989
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 11 (2) , 133-147
- https://doi.org/10.1016/0192-0561(89)90065-9
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Effect of tumor inhibitory and stimulatory doses of levan, alone and in combination with cyclophosphamide, on spleen and lymph nodesInternational Journal of Immunopharmacology, 1986
- Effect of splenectomy on the efficiency of chemo-immunotherapy of melanoma-bearing miceInternational Journal of Immunopharmacology, 1985
- Increase of natural killer (NK) activity of mouse lymphocytes following in vitro treatment with cytosine-arabinosideInternational Journal of Immunopharmacology, 1984
- The negative systemic effect of BCGcw inoculated intraperitoneallyCancer Immunology, Immunotherapy, 1981
- The role of macrophages and polymorphs in the levan-induced inhibition of Lewis lung carcinoma in C57BL miceBritish Journal of Cancer, 1979
- The suppressor mechanisms and their significance in tumor immunologyCancer Immunology, Immunotherapy, 1978
- Effects of amputation and Corynebacterium parvum on tumour metastases in miceBritish Journal of Cancer, 1978
- B-cell suppression of delayed hypersensitivity reactionsNature, 1974
- Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.British Journal of Cancer, 1969
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969